1. Emicizumab does not interfere with the activated clotting time. Issue 2 (21st January 2022) Authors: Capdevila, Ladislas; Frère, Corinne; Desvages, Maximilien; Harroche, Annie; Bally, Cécile; Abbes, Ahmed; d'Oiron, Roseline; Frenzel, Laurent; Borgel, Delphine; Lasne, Dominique Journal: Haemophilia Issue: Volume 28:Issue 2(2022) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy. Issue 4 (18th May 2021) Authors: Capdevila, Ladislas; Borgel, Delphine; Lasne, Dominique; Lacroix‐Desmazes, Sebastien; Desvages, Maximilien; Delignat, Sandrine; Bally, Cécile; Frenzel, Laurent; Harroche, Annie Journal: Haemophilia Issue: Volume 27:Issue 4(2021) Page Start: e581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗